Results 341 to 350 of about 714,034 (377)
Some of the next articles are maybe not open access.
The American Journal of Surgery, 1989
The overall cure rate for gastric cancer has changed relatively little in the United States over the past 30 years, largely because patients continue to present for treatment in advanced stages. The paucity of symptoms in early gastric cancer, the low incidence in the general United States population, and the lack of cost-effective screening methods ...
A W, Boddie, C M, McBride, C M, Balch
openaire +2 more sources
The overall cure rate for gastric cancer has changed relatively little in the United States over the past 30 years, largely because patients continue to present for treatment in advanced stages. The paucity of symptoms in early gastric cancer, the low incidence in the general United States population, and the lack of cost-effective screening methods ...
A W, Boddie, C M, McBride, C M, Balch
openaire +2 more sources
Current Opinion in Gastroenterology, 2000
Gastric adenocarcinoma is the most common malignancy of the upper gastrointestinal tract. During the past two decades it has migrated toward the gastroesophageal junction. Gastroesophageal reflux and obesity may play a role. Recent research suggests that a number of biologic and molecular differences exist in patients with gastric cancer.
J C, Yao, J A, Ajani
openaire +2 more sources
Gastric adenocarcinoma is the most common malignancy of the upper gastrointestinal tract. During the past two decades it has migrated toward the gastroesophageal junction. Gastroesophageal reflux and obesity may play a role. Recent research suggests that a number of biologic and molecular differences exist in patients with gastric cancer.
J C, Yao, J A, Ajani
openaire +2 more sources
Chemotherapy of gastric cancer
Anti-Cancer Drugs, 1996Patients with gastric adenocarcinomas have a poor prognosis. Because curative surgery is often impossible (metastatic disease) or extremely difficult (locally advanced tumors), and the majority of patients undergoing curative resection relapse, chemotherapy has been actively studied in gastric cancer.
Schipper, D.L., Wagener, D.J.T.
openaire +5 more sources
The Lancet, 2016
Gastric cancer is one of the leading causes of cancer-related death worldwide. Many patients have inoperable disease at diagnosis or have recurrent disease after resection with curative intent. Gastric cancer is separated anatomically into true gastric adenocarcinomas and gastro-oesophageal-junction adenocarcinomas, and histologically into diffuse and ...
Eric, Van Cutsem +4 more
openaire +2 more sources
Gastric cancer is one of the leading causes of cancer-related death worldwide. Many patients have inoperable disease at diagnosis or have recurrent disease after resection with curative intent. Gastric cancer is separated anatomically into true gastric adenocarcinomas and gastro-oesophageal-junction adenocarcinomas, and histologically into diffuse and ...
Eric, Van Cutsem +4 more
openaire +2 more sources
Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer
2016Gastric cancer is the fifth most common cancer accounting for close to 7 % of all human cancers. Despite the decrease in incidence, gastric cancer remains the most common cause of gastrointestinal cancer-related death, with more than 800,000 fatalities annually.
openaire +2 more sources
Der Pathologe, 2012
In 1998, Guilford et al. identified the hereditary diffuse gastric cancer (HDGC) syndrome, caused by germline alterations at the CDH1 (E-cadherin) gene. To date, 141 probands harboring more than 100 different germline CDH1 alterations, mainly point mutations and large deletions, have been described.
Fátima Carneiro, Fátima Carneiro
openaire +4 more sources
In 1998, Guilford et al. identified the hereditary diffuse gastric cancer (HDGC) syndrome, caused by germline alterations at the CDH1 (E-cadherin) gene. To date, 141 probands harboring more than 100 different germline CDH1 alterations, mainly point mutations and large deletions, have been described.
Fátima Carneiro, Fátima Carneiro
openaire +4 more sources
Chemoprevention of gastric cancer
European Journal of Gastroenterology & Hepatology, 2006Gastric cancer is the second commonest cause of cancer-associated death in the world. The high mortality is largely attributed to the huge number of at-risk individuals as well as the delay in presentation. Hence, chemoprevention of gastric cancer appears to be the most promising approach in reducing the incidence and mortality related to this cancer ...
Leung, WK, Sung, JJY
openaire +5 more sources
Gastric Cancer: First Relatives of Gastric Cancer
2016Family history is an important risk factor of gastric cancer and can be seen from 10 % to 15 % of gastric cancer patients. This factor is partially explained by genetic and environmental factors, and family history is also related to familial clustering of Helicobacter pylori (H. pylori) infection.
Nayoung Kim, Yoon Jin Choi
openaire +2 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly